Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Evaluating Chemotherapy-induced Nausea and Vomiting and Food Intake in Patients With Gynecologic Cancer.

Komatsu H, Oishi T, Sato S, Osaku D, Sawada M, Kudoh A, Nonaka M, Sato S, Shimada M, Itamochi H, Harada T.

Anticancer Res. 2019 Aug;39(8):4555-4560. doi: 10.21873/anticanres.13633.

PMID:
31366559
2.

Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.

Sawada M, Oishi T, Komatsu H, Sato S, Chikumi J, Nonaka M, Kudoh A, Osaku D, Harada T.

Int J Clin Oncol. 2019 Jun 24. doi: 10.1007/s10147-019-01495-x. [Epub ahead of print]

PMID:
31236742
3.

Recurrent colon perforation after discontinuation of bevacizumab for ovarian cancer.

Nonaka M, Sato S, Osaku D, Sawada M, Kudoh A, Chikumi J, Sato S, Oishi T, Harada T.

Gynecol Oncol Rep. 2018 Aug 24;26:21-23. doi: 10.1016/j.gore.2018.08.005. eCollection 2018 Nov.

4.

Significance of High-Risk Human Papillomavirus Testing for Atypical Glandular Cells on Cervical Cytology.

Komatsu H, Oishi T, Osaku D, Sawada M, Kudoh A, Nonaka M, Chikumi J, Sato S, Harada T.

Acta Cytol. 2018;62(5-6):405-410. doi: 10.1159/000490230. Epub 2018 Jul 10.

PMID:
29990964
5.

Preliminary Evidence for Adipocytokine Signals in Skeletal Muscle Glucose Uptake.

Kudoh A, Satoh H, Hirai H, Watanabe T, Shimabukuro M.

Front Endocrinol (Lausanne). 2018 Jun 7;9:295. doi: 10.3389/fendo.2018.00295. eCollection 2018.

6.

The tumour suppressor APC promotes HIV-1 assembly via interaction with Gag precursor protein.

Miyakawa K, Nishi M, Matsunaga S, Okayama A, Anraku M, Kudoh A, Hirano H, Kimura H, Morikawa Y, Yamamoto N, Ono A, Ryo A.

Nat Commun. 2017 Jan 30;8:14259. doi: 10.1038/ncomms14259.

7.

H11/HSPB8 Restricts HIV-2 Vpx to Restore the Anti-Viral Activity of SAMHD1.

Kudoh A, Miyakawa K, Matsunaga S, Matsushima Y, Kosugi I, Kimura H, Hayakawa S, Sawasaki T, Ryo A.

Front Microbiol. 2016 Jun 13;7:883. doi: 10.3389/fmicb.2016.00883. eCollection 2016.

8.

Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.

Sato S, Itamochi H, Oumi N, Chiba Y, Oishi T, Shimada M, Sato S, Chikumi J, Nonaka M, Kudoh A, Komatsu H, Harada T, Sugiyama T.

Hum Cell. 2016 Oct;29(4):181-7. doi: 10.1007/s13577-016-0138-6. Epub 2016 Mar 9.

PMID:
26960408
9.

Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.

Kudoh A, Sato S, Itamochi H, Komatsu H, Nonaka M, Sato S, Chikumi J, Shimada M, Oishi T, Kigawa J, Harada T.

Int J Clin Oncol. 2016 Jun;21(3):580-7. doi: 10.1007/s10147-015-0929-x. Epub 2015 Nov 27.

PMID:
26614089
10.

Establishment and mutation analysis of a novel malignant peritoneal mesothelioma cell line, TU-MM-1, using whole genome sequencing.

Oumi N, Itamochi H, Komatsu H, Oishi T, Shimada M, Sato S, Chikumi J, Sato S, Nonaka M, Kudoh A, Harada T.

Hum Cell. 2016 Jan;29(1):46-51. doi: 10.1007/s13577-015-0120-8. Epub 2015 Jun 13.

PMID:
26070481
11.

MUC5B mucin production is upregulated by fibronectin and laminin in human lung epithelial cells via the integrin and ERK dependent pathway.

Ito Y, Iwashita J, Kudoh A, Kuramata C, Murata J.

Biosci Biotechnol Biochem. 2015;79(11):1794-801. doi: 10.1080/09168451.2015.1052769. Epub 2015 Jun 9.

PMID:
26057585
12.

ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.

Miyakawa K, Matsunaga S, Kanou K, Matsuzawa A, Morishita R, Kudoh A, Shindo K, Yokoyama M, Sato H, Kimura H, Tamura T, Yamamoto N, Ichijo H, Takaori-Kondo A, Ryo A.

Nat Commun. 2015 Apr 22;6:6945. doi: 10.1038/ncomms7945.

13.

Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.

Nishi M, Akutsu H, Kudoh A, Kimura H, Yamamoto N, Umezawa A, Lee SW, Ryo A.

Oncotarget. 2014 Sep 30;5(18):8665-80.

14.
15.

The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma.

Oishi T, Itamochi H, Kudoh A, Nonaka M, Kato M, Nishimura M, Oumi N, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.

Oncol Rep. 2014 Aug;32(2):553-8. doi: 10.3892/or.2014.3268. Epub 2014 Jun 13.

PMID:
24927217
16.

Wheat germ cell-free system-based production of hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 for generation and characterization of monoclonal antibody.

Matsunaga S, Kawakami S, Matsuo I, Okayama A, Tsukagoshi H, Kudoh A, Matsushima Y, Shimizu H, Okabe N, Hirano H, Yamamoto N, Kimura H, Ryo A.

Front Microbiol. 2014 May 13;5:208. doi: 10.3389/fmicb.2014.00208. eCollection 2014.

17.

Dual inhibition of phosphatidylinositol 3'-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach for mucinous adenocarcinoma of the ovary.

Kudoh A, Oishi T, Itamochi H, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.

Int J Gynecol Cancer. 2014 Mar;24(3):444-53. doi: 10.1097/IGC.0000000000000091.

PMID:
24552895
18.

The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.

Kudoh A, Takahama S, Sawasaki T, Ode H, Yokoyama M, Okayama A, Ishikawa A, Miyakawa K, Matsunaga S, Kimura H, Sugiura W, Sato H, Hirano H, Ohno S, Yamamoto N, Ryo A.

Retrovirology. 2014 Jan 22;11:9. doi: 10.1186/1742-4690-11-9.

19.

Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.

Itamochi H, Nishimura M, Oumi N, Kato M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Kudoh A, Kigawa J, Harada T.

Int J Gynecol Cancer. 2014 Jan;24(1):61-9. doi: 10.1097/IGC.0000000000000014.

PMID:
24362713
20.

Yacon diet (Smallanthus sonchifolius, Asteraceae) improves hepatic insulin resistance via reducing Trb3 expression in Zucker fa/fa rats.

Satoh H, Audrey Nguyen MT, Kudoh A, Watanabe T.

Nutr Diabetes. 2013 May 27;3:e70. doi: 10.1038/nutd.2013.11.

21.

Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.

Itamochi H, Kato M, Nishimura M, Oumi N, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Nonaka M, Kudoh A, Terakawa N, Kigawa J, Harada T.

Hum Cell. 2013 Sep;26(3):121-7. doi: 10.1007/s13577-013-0062-y. Epub 2013 Feb 21.

PMID:
23430509
22.

Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2.

Itamochi H, Kato M, Nishimura M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Nonaka M, Kudoh A, Terakawa N, Kigawa J, Harada T.

Hum Cell. 2012 Dec;25(4):111-5. doi: 10.1007/s13577-012-0048-1. Epub 2012 Dec 30.

PMID:
23274876
23.

Interaction between resistin and adiponectin in the proliferation of rat vascular smooth muscle cells.

Hirai H, Satoh H, Kudoh A, Watanabe T.

Mol Cell Endocrinol. 2013 Feb 5;366(1):108-16. doi: 10.1016/j.mce.2012.12.009. Epub 2012 Dec 23.

PMID:
23267839
24.

Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.

Nonaka M, Itamochi H, Kawaguchi W, Kudoh A, Sato S, Uegaki K, Naniwa J, Sato S, Shimada M, Oishi T, Terakawa N, Kigawa J, Harada T.

Int J Gynecol Cancer. 2012 Jul;22(6):922-9. doi: 10.1097/IGC.0b013e31824f0b13.

PMID:
22672985
25.

Significant differences in the cell-wall mannans from three Candida glabrata strains correlate with antifungal drug sensitivity.

Takahashi S, Kudoh A, Okawa Y, Shibata N.

FEBS J. 2012 May;279(10):1844-56. doi: 10.1111/j.1742-4658.2012.08564.x. Epub 2012 Apr 4.

26.

[Renal-salt wasting syndrome in a patient with CDDP containing chemotherapy for recurrent non-small-cell lung cancer].

Suzuki H, Ohsugi J, Saito T, Hoshino M, Higuchi M, Kitamura M, Kudoh A, Midorikawa S, Gotoh M.

Gan To Kagaku Ryoho. 2011 Dec;38(13):2635-8. Japanese.

PMID:
22189232
27.

Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats.

Nakamaki S, Satoh H, Kudoh A, Hayashi Y, Hirai H, Watanabe T.

Exp Biol Med (Maywood). 2011 May 1;236(5):614-20. doi: 10.1258/ebm.2011.010218. Epub 2011 Apr 26.

PMID:
21521713
28.

Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes.

Kudoh A, Satoh H, Hirai H, Watanabe T.

Life Sci. 2011 Jun 6;88(23-24):1055-62. doi: 10.1016/j.lfs.2011.04.001. Epub 2011 Apr 14.

PMID:
21514306
29.

[Preoperative evaluation, preparation and prognosis in depressed patients].

Kudoh A.

Masui. 2010 Sep;59(9):1116-27. Review. Japanese.

PMID:
20857666
30.

[Preoperative assessment, preparation and prospect of prognosis in schizophrenic patients].

Kudoh A.

Masui. 2010 Sep;59(9):1105-15. Review. Japanese.

PMID:
20857665
31.

Amount of bone lengthening affects blood flow recovery and bone mineralization after distraction osteogenesis in a canine cleft palate model.

Aoki A, Kawamoto T, Aoki K, Inokuchi T, Kudoh A, Nagahama K, Baba Y, Suzuki S, Ohya K, Moriyama K.

Cleft Palate Craniofac J. 2010 May;47(3):303-13. doi: 10.5555/08-019.1.

PMID:
20426679
32.

Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replication.

Sato Y, Shirata N, Murata T, Nakasu S, Kudoh A, Iwahori S, Nakayama S, Chiba S, Isomura H, Kanda T, Tsurumi T.

Cell Cycle. 2010 Feb 15;9(4):807-14. Epub 2010 Feb 17.

PMID:
20139729
33.

Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.

Sato Y, Kamura T, Shirata N, Murata T, Kudoh A, Iwahori S, Nakayama S, Isomura H, Nishiyama Y, Tsurumi T.

PLoS Pathog. 2009 Jul;5(7):e1000530. doi: 10.1371/journal.ppat.1000530. Epub 2009 Jul 31.

34.

Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.

Nakayama S, Murata T, Murayama K, Yasui Y, Sato Y, Kudoh A, Iwahori S, Isomura H, Kanda T, Tsurumi T.

J Biol Chem. 2009 Aug 7;284(32):21557-68. doi: 10.1074/jbc.M109.015685. Epub 2009 Jun 2.

35.

Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication.

Iwahori S, Murata T, Kudoh A, Sato Y, Nakayama S, Isomura H, Kanda T, Tsurumi T.

J Biol Chem. 2009 Jul 10;284(28):18923-31. doi: 10.1074/jbc.M109.015123. Epub 2009 May 18.

36.

Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase.

Murata T, Isomura H, Yamashita Y, Toyama S, Sato Y, Nakayama S, Kudoh A, Iwahori S, Kanda T, Tsurumi T.

Virology. 2009 Jun 20;389(1-2):75-81. doi: 10.1016/j.virol.2009.04.007. Epub 2009 May 8.

37.

Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments.

Kudoh A, Iwahori S, Sato Y, Nakayama S, Isomura H, Murata T, Tsurumi T.

J Virol. 2009 Jul;83(13):6641-51. doi: 10.1128/JVI.00049-09. Epub 2009 Apr 22.

38.

Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription.

Sato Y, Shirata N, Kudoh A, Iwahori S, Nakayama S, Murata T, Isomura H, Nishiyama Y, Tsurumi T.

Virology. 2009 May 25;388(1):204-11. doi: 10.1016/j.virol.2009.03.017. Epub 2009 Apr 16.

39.

TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein.

Murata T, Sato Y, Nakayama S, Kudoh A, Iwahori S, Isomura H, Tajima M, Hishiki T, Ohshima T, Hijikata M, Shimotohno K, Tsurumi T.

J Biol Chem. 2009 Mar 20;284(12):8033-41. doi: 10.1074/jbc.M808466200. Epub 2009 Jan 21.

40.

Identification of phosphorylation sites on transcription factor Sp1 in response to DNA damage and its accumulation at damaged sites.

Iwahori S, Yasui Y, Kudoh A, Sato Y, Nakayama S, Murata T, Isomura H, Tsurumi T.

Cell Signal. 2008 Oct;20(10):1795-803. doi: 10.1016/j.cellsig.2008.06.007. Epub 2008 Jun 19.

PMID:
18619531
41.

Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.

Takamatsu S, Noguchi N, Kudoh A, Nakamura N, Kawamura T, Teramoto K, Igari T, Arii S.

Hepatogastroenterology. 2008 Mar-Apr;55(82-83):609-14.

PMID:
18613418
42.
43.

Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells.

Ijichi K, Adachi M, Hasegawa Y, Ogawa T, Nakamura H, Kudoh A, Yasui Y, Murakami S, Ishizaki K.

Cancer Chemother Pharmacol. 2008 Oct;62(5):745-52. Epub 2007 Dec 13.

PMID:
18075740
44.

Noncanonical TATA sequence in the UL44 late promoter of human cytomegalovirus is required for the accumulation of late viral transcripts.

Isomura H, Stinski MF, Kudoh A, Murata T, Nakayama S, Sato Y, Iwahori S, Tsurumi T.

J Virol. 2008 Feb;82(4):1638-46. Epub 2007 Dec 5.

45.

A cis element between the TATA Box and the transcription start site of the major immediate-early promoter of human cytomegalovirus determines efficiency of viral replication.

Isomura H, Stinski MF, Kudoh A, Nakayama S, Murata T, Sato Y, Iwahori S, Tsurumi T.

J Virol. 2008 Jan;82(2):849-58. Epub 2007 Nov 7.

46.

[Severe hypoxia during right lateral position induced by mediastinal shift].

Yasuda T, Matsuno S, Kudoh A.

Masui. 2007 Sep;56(9):1071-4. Japanese.

PMID:
17877049
47.

[Replication of DNA viruses and host DNA damage responses].

Tsurumi T, Kudoh A.

Tanpakushitsu Kakusan Koso. 2007 Aug;52(10 Suppl):1155-60. Review. Japanese. No abstract available.

PMID:
17824233
48.

Adaptive optics instrumentation in submillimeter/terahertz spectroscopy with a flexible polyvinylidene fluoride cladding hollow waveguide.

Hidaka T, Ishikawa A, Kojou J, Ikari T, Ishikawa Y, Minamide H, Kudoh A, Nishizawa J, Ito H.

Rev Sci Instrum. 2007 Aug;78(8):086109.

PMID:
17764369
49.

Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein.

Iwahori S, Shirata N, Kawaguchi Y, Weller SK, Sato Y, Kudoh A, Nakayama S, Isomura H, Tsurumi T.

J Virol. 2007 Sep;81(18):9653-64. Epub 2007 Jul 3.

50.

Supplemental Content

Support Center